Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiko Kuwano

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Pharmaceutical Research|March 1, 2003
Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesiclesFumihiko Ushigome, Noriko Koyabu, Shoji Satoh, et al.
Cancer Science|April 2, 2008
Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcomaYoshinao Oda, Kenichi Kohashi, Hidetaka Yamamoto, et al.
Cancer Science|April 27, 2007
Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expressionYoshinao Oda, Yoshihiro Ohishi, Yuji Basaki, et al.
Molecular Cancer Therapeutics|March 1, 2013
Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cellsTomohiro Shibata, Hitoshi Kan, Yuichi Murakami, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activationKosuke Watari, Shintaro Nakao, Abbas Fotovati, et al.
Oncotarget|June 23, 2016
Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinomaKosuke Watari, Ayumi Nishitani, Tomohiro Shibata, et al.
International Journal of Cancer|August 10, 2011
The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathwayKosuke Watari, Mamiyo Nakamura, Yuichi Fukunaga, et al.
Cancer Science|April 10, 2004
Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin CKotaro Shibahara, Takeshi Uchiumi, Takao Fukuda, et al.
Journal of Pediatric Surgery|November 21, 2007
Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastomaSuguru Fukahori, Hirohisa Yano, Makoto Tsuneoka, et al.
Cancer Research|June 4, 2009
N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expressionFumihito Hosoi, Hiroto Izumi, Akihiko Kawahara, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Pharmaceutical Research|March 1, 2003
Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesiclesFumihiko Ushigome, Noriko Koyabu, Shoji Satoh, et al.
Cancer Science|April 2, 2008
Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcomaYoshinao Oda, Kenichi Kohashi, Hidetaka Yamamoto, et al.
Cancer Science|April 27, 2007
Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expressionYoshinao Oda, Yoshihiro Ohishi, Yuji Basaki, et al.
Molecular Cancer Therapeutics|March 1, 2013
Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cellsTomohiro Shibata, Hitoshi Kan, Yuichi Murakami, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activationKosuke Watari, Shintaro Nakao, Abbas Fotovati, et al.
Oncotarget|June 23, 2016
Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinomaKosuke Watari, Ayumi Nishitani, Tomohiro Shibata, et al.
International Journal of Cancer|August 10, 2011
The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathwayKosuke Watari, Mamiyo Nakamura, Yuichi Fukunaga, et al.
Cancer Science|April 10, 2004
Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin CKotaro Shibahara, Takeshi Uchiumi, Takao Fukuda, et al.
Journal of Pediatric Surgery|November 21, 2007
Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastomaSuguru Fukahori, Hirohisa Yano, Makoto Tsuneoka, et al.
Cancer Research|June 4, 2009
N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expressionFumihito Hosoi, Hiroto Izumi, Akihiko Kawahara, et al.
Pageof 15